A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection
Ross E. McKinney(Environmental Protection Agency), Stephen A. Spector(University of California San Diego), Amy Keller(Duke University), Florence H. Yong(MelroseWakefield Healthcare), Pim Brouwers(National Institutes of Health), James McNamara(National Institute of Allergy and Infectious Diseases), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Karen O’Donnell(Duke Medical Center), Diane W. Wara(University of California, San Francisco), Kenneth Stanley(Harvard University Press), George M. Johnson(Duke University), Ram Yogev(Northwestern University), Andrew Wiznia(Jacobi Medical Center), Wendy G. Mitchell(University of Southern California)
Cited by 107
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697